Boris Fehse

42PUBLICATIONS
141CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesAllergyCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Apr 15, 2026
A new therapeutic frontier: CD19-targeting CAR-T cell therapy in rheumatoid arthritis: a concise report.

|Mar 19, 2026
Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.

Denisa Bojkova, Katja Steinhorst, Marco Bechtel

|Feb 02, 2026
Novel Bispecific Engagers Targeting the CεmX Domain of mIgE-Expressing Cells.

Constantin Möller, Julia Hambach, Alessa Zoe Schaffrath

|Jan 13, 2026
Multiple signaling events are required for NAADP synthesis by DUOX2 and formation of Ca2+ microdomains to initiate T cell activation.

Kai J Winterberg, Vanessa Schwentner, Feng Gu

|Apr 23, 2025
A novel approach to refractory idiopathic inflammatory myopathy: CD19 CAR T-cell therapy-case report and literature review.

Isabell Haase, Johanna Richter, Marie-Therese Holzer

|Dec 07, 2024
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation.

Anne Kruchen, Boris Fehse, Ingo Müller

Pageof 7

Frequent Collaborators

17 joint publications

Kristoffer Riecken

4 joint publications

Ingo Müller

4 joint publications

Lea Isabell Schwarze

3 joint publications

Francis Ayuk